JULY 2024LIFE SCIENCES REVIEW5Marianthi Psacha, President,Head Europe, Middle East & Africa, Santen PharmaceuticalHow we're Leveraging New Technological Advancements by Building a Cell & Gene Therapy Business unit within an Established Pharmaceutical Company17Rafael Sande, Head Operations Characterization, Large Molecules and ATMP Services, Solvias AGEarly Phase Biologics Characterization; a Key Factor for Risks Mitigation in Biologics Product Developments21Matthew Hewitt, Vice President, Technical Officer CGT & Biologics, Charles River LaboratoriesThe Evolving Cell and Gene Therapy Space28FEATURED COMPANYpg no - 14CXO INSIGHTSDr. Fahad Attar,Consultant Orthopaedic Surgeon and CEO26RegenesissGermar Wittke, Biopharma Sales Director, EMEAAndrea Gough, Director, Solentim Portfolio and Science ApplicationsAdvanced Instruments18TOP 10Cell andGene TherapyCOMPANIES IN EUROPE 2024COMPANY OF THE YEARTOP 5Cell andGene TherapyCOMPANIES IN UK 2024
< Page 4 | Page 6 >